Cornelia McCluskey, MD
Radiation Oncology · Cincinnati, OHNPI 1467448548
Payments from drug & device makers
Across 25 payments — averaging $16.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$43
- Spectrum Pharmaceuticals Inc.$30
- Monteris Medical Corporation$30
- Seagen Inc.$29
- Sanofi$25
- Tempus AI, Inc$22
- plus $225 from 16 others
What the payments were for
- Food & beverage$403100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 3 | $43 |
| Spectrum Pharmaceuticals Inc. | 1 | $30 |
| Monteris Medical Corporation | 1 | $30 |
| Seagen Inc. | 2 | $29 |
| Sanofi | 1 | $25 |
| Tempus AI, Inc | 1 | $22 |
| Adaptive Biotechnologies Corporation | 1 | $20 |
| Pfizer | 1 | $19 |
| Novartis | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Siemens Medical Solutions USA, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Merck | 1 | $13 |
| Amgen | 1 | $13 |
| Bayer | 1 | $13 |
| AstraZeneca | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Puma Biotechnology, Inc. | 1 | $11 |
| Varian Medical Systems, Inc. | 1 | $11 |
| Secura Bio, Inc. | 1 | $9 |
How this compares
$403 in reported general payments places this provider in the 50th percentile of 255 radiation oncology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cevimeline Hcl | 14 | $1,845 |
| Mometasone Furoate | 20 | $400 |
| Pilocarpine Hcl | 11 | $359 |
| Nystatin | 16 | $159 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Cincinnati
- John BrenemanCincinnati$503K
- Kyle WangCincinnati$412K
- Joseph ShaughnessyCincinnati$242K
- Emily DaughertyCincinnati$213K
- Sara MedekCincinnati$54K
- Bryan RabaticCincinnati$47K
- David LongCincinnati$46K
- Jordan KharofaCincinnati$13K
- Matthew BertkeCincinnati$5K
- Shlomo KoyfmanCleveland$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.